Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

180

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N07BB03	ACAMPROSATE BIOGARAN	G	Acamprosate - 333mg	333mg	Tablet, gastroresistant	3,641,813 L.L
V01AA	ACARIZAX 12 SQ-HDM ORAL LYOPHILISATE	B	Allergen extracts - 12 SQ-HDM		Tablet, lyophilised	9,366,451 L.L
J01AA02	TOLEXINE	G	Doxycycline (monohydrate) - 100mg	100mg	Tablet, microgranules	589,947 L.L
J01FA09	KLACID RM	B	Clarithromycin - 500mg	500mg	Tablet, modified release	1,173,175 L.L
A07EC02	ASACOL	B	Mesalazine - 1600mg	1600mg	Tablet, modified release	8,454,523 L.L
A07EC02	ASACOL	B	Mesalazine - 1600mg	1600mg	Tablet, modified release	12,310,378 L.L
N02AX02	TRAMAL RETARD	B	Tramadol HCl - 100mg	100mg	Tablet, modified release	236,516 L.L
N02AX02	TRAMAL RETARD	B	Tramadol HCl - 150mg	150mg	Tablet, modified release	356,118 L.L
G04CA01	PROSTETROL	G	Alfuzosin HCl - 10mg	10mg	Tablet, modified release	360,150 L.L
N02AX02	TRAMAL RETARD	B	Tramadol HCl - 200mg	200mg	Tablet, modified release	474,376 L.L
G04CA01	PROSTETROL	G	Alfuzosin HCl - 10mg	10mg	Tablet, modified release	682,672 L.L
G04CA53	VESOMNI	B	Tamsulosin HCl - 0.4mg, Solifenacin succinate - 6mg		Tablet, modified release	4,491,122 L.L
A10BB09	DIAMICRON MR	B	Gliclazide - 60mg	60mg	Tablet, modified release	382,995 L.L
C08DA51	TARKA	B	Verapamil - 240mg, Trandolapril - 4mg		Tablet, modified release	3,797,532 L.L
N05AH03	OLANZAX 5	G	Olanzapine - 5mg	5mg	Tablet, mouth dissolving	1,316,966 L.L
N05AH03	OLIZAX 5	G	Olanzapine - 5mg	5mg	Tablet, mouth dissolving	1,466,580 L.L
N05AH03	OLANZAX 10	G	Olanzapine - 10mg	10mg	Tablet, mouth dissolving	2,329,327 L.L
N05AH03	OLIZAX 10	G	Olanzapine - 10mg	10mg	Tablet, mouth dissolving	2,598,096 L.L
R03DC03	ROMILAST	G	Montelukast (sodium) - 5mg	5mg	Tablet, mouth dissolving	518,723 L.L
R03DC03	ROMILAST	G	Montelukast (sodium) - 4mg	4mg	Tablet, mouth dissolving	405,840 L.L
H01BA02	MINIRIN MELT	B	Desmopressin - 120mcg	120mcg	Tablet, Oral lyophilisate	4,970,873 L.L
H01BA02	MINIRIN MELT	B	Desmopressin - 60mcg	60mcg	Tablet, Oral lyophilisate	2,484,765 L.L
G04BE09	VERDA	G	Vardenafil (HCl) - 10mg	10mg	Tablet, orally disintegrating	1,023,880 L.L
N05AH03	APO-OLANZAPINE ODT	G	Olanzapine - 5mg	5mg	Tablet, orally disintegrating	1,463,444 L.L
N05AH03	APO-OLANZAPINE ODT	G	Olanzapine - 10mg	10mg	Tablet, orally disintegrating	2,422,948 L.L
N05AX08	RISCHOTIC OD 1	G	Risperidone - 1mg	1mg	Tablet, orally disintegrating	371,157 L.L
N05AX08	RISCHOTIC OD 2	G	Risperidone - 2mg	2mg	Tablet, orally disintegrating	371,157 L.L
N05AX08	RISCHOTIC OD 3	G	Risperidone - 3mg	3mg	Tablet, orally disintegrating	605,369 L.L
N05AX08	RISCHOTIC OD 4	G	Risperidone - 4mg	4mg	Tablet, orally disintegrating	605,369 L.L
A07DA03	IMODIUM INSTANTS	B	Loperamide HCl - 2mg	2mg	Tablet, orodispersible	451,531 L.L

...

180

...